B
- Beta-agonist
- A medicine that relaxes the muscles around the airways and thereby eases restricted breathing during an asthma attack or in chronic obstructive pulmonary disease.
- Beta-blocker
- A medicine used to treat various cardiovascular diseases that acts by blocking receptors at nerve endings.
- Biomarker
- A characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention.
- Biopharmaceuticals/Biologics
- A class of medicines derived from proteins usually produced naturally by living organisms in response to disease, for example antibodies.
- Biosimilars
- Follow-on biopharmaceuticals that are biologically similar to an existing medicine.
- Bipolar disorder
- Any of several mood disorders characterised usually by alternating episodes of depression and mania or by episodes of depression alternating with mild non-psychotic excitement.
- Board
- The Board of Directors of AstraZeneca PLC.
- BRCA-mutated breast cancer
- A form of breast cancer caused by the mutation of the gene that normally acts to restrain the growth of cells in the breast.
- Bronchodilator
- A drug that causes the widening of the bronchi (major air passages of the lungs).
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceOur responsibility
We continue to communicate openly on a range of issues, including:
